Cross‐National Study to Operationalize Amyloid, Tau, Neurodegeneration, and Vascular Contributions to Dementia
Jeremy A. Tanner, Diefei Chen, Min Soo Byun, Evgeny J. Chumin, Ileana De Anda‐Duran, Kacie D Deters, Martine Elbejjani, Evan Fletcher, A. Zarina Kraal, Dong Young Lee, Silvia Mejia‐Arango, Stefanie Pina‐Escudero, Kwangsik Nho, Talia L. Robinson, C. Elizabeth Shaaban

TL;DR
This study compares methods to diagnose dementia using brain scans and biomarkers in U.S. and Korean populations, finding that continuous measures work best for research.
Contribution
The paper introduces a cross-national comparison of multimodal biomarker operationalization for dementia diagnosis, highlighting regional differences in model performance.
Findings
Models with continuous ATNV measures explained more dementia diagnosis variability in the U.S. cohort.
Korean models showed higher predictive power when including binary N and binary A.
Continuous variables are optimal for research, while binary variables may enhance clinical predictions in specific regions.
Abstract
Recent diagnosis and staging criteria have been proposed for AD based on amyloid(“A”), tau(“T”), and neurodegeneration(“N”), with consideration of comorbid vascular(“V”) pathology. However, challenges remain in their application and interpretation for research and clinical use. Additionally, current criteria have been largely informed by data derived from samples of highly educated, non‐Hispanic White cohorts in the US. We compared methods to operationalize multimodal ATNV measures across two cohorts to meaningfully inform future research and clinical practice. Participants with amyloid PET, tau PET, and brain MRI were included from two prospective cohort studies with similar study designs: ADNI3 in the US and KBASE in Korea. ATNV measures were operationalized as continuous (A=centiloid; T=meta‐temporal ROI; N = AD signature region cortical thickness; V=white matter hyperintensity…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDementia and Cognitive Impairment Research · Alzheimer's disease research and treatments · Neurological Disease Mechanisms and Treatments
